We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Kinder Morgan
KMI
$70.4B
| $12M | 0.03% |
714,750
-2,176,938
| -75% | -$40.8M |
|
627
Zimmer Biomet
ZBH
$18.6B
| $11.9M | 0.03% |
114,763
-11,692
| -9% | -$1.39M |
|
628
Euronet Worldwide
EEFT
$2.65B
| $11.7M | 0.03% |
117,472
+9,783
| +9% | +$1.16M |
|
629
MasTec
MTZ
$22.1B
| $11.7M | 0.03% |
165,728
+68,008
| +70% | +$5.3M |
|
630
Huazhu Hotels Group
HTHT
$12.7B
| $11.6M | 0.03% |
304,603
-6,088
| -2% | -$191K |
|
631
CoStar Group
CSGP
$12.6B
| $11.6M | 0.03% |
197,995
-104,433
| -35% | -$6.33M |
|
632
Domino's
DPZ
$11.8B
| $11.4M | 0.03% |
29,358
-49,348
| -63% | -$18.3M |
|
633
Mid-America Apartment Communities
MAA
$15.4B
| $11.3M | 0.03% |
65,716
+43,092
| +190% | +$8.01M |
|
634
Universal Display
OLED
$4.26B
| $11.3M | 0.03% |
112,987
+10,695
| +10% | +$1.38M |
|
635
American Express
AXP
$231B
| $11.3M | 0.03% |
83,701
+12,332
| +17% | +$2.04M |
|
636
EPR Properties
EPR
$4.57B
| $11.3M | 0.03% |
242,214
+23,234
| +11% | +$1.18M |
|
637
eBay
EBAY
$47.4B
| $11.2M | 0.03% |
273,227
-73,683
| -21% | -$3.59M |
|
638
Prosperity Bancshares
PB
$8.88B
| $11.2M | 0.03% |
166,898
-135,712
| -45% | -$9.32M |
|
639
Pinterest
PINS
$13.5B
| $11.2M | 0.03% |
614,531
-77,577
| -11% | -$1.62M |
|
640
MGIC Investment
MTG
$6.27B
| $11.1M | 0.03% |
897,136
+842,349
| +1,537% | +$11.1M |
|
641
Delta Air Lines
DAL
$59.1B
| $11.1M | 0.03% |
392,766
-90,454
| -19% | -$3.45M |
|
642
Analog Devices
ADI
$189B
| $11M | 0.02% |
76,568
-21,450
| -22% | -$3.38M |
|
|
WWE
643
DELISTED
World Wrestling Entertainment
WWE
| $11M | 0.02% |
178,241
-108,094
| -38% | -$6.68M |
|
644
L3Harris
LHX
$53.6B
| $10.8M | 0.02% |
45,808
-89,738
| -66% | -$21.7M |
|
645
WEX
WEX
$6.46B
| $10.8M | 0.02% |
72,054
-6,768
| -9% | -$1.11M |
|
646
MGM Resorts International
MGM
$11B
| $10.8M | 0.02% |
379,842
-264,554
| -41% | -$9.49M |
|
|
GAP
647
The Gap Inc
GAP
$7.61B
| $10.7M | 0.02% |
1,303,471
+674,540
| +107% | +$7.8M |
|
648
NNN REIT
NNN
$8.73B
| $10.7M | 0.02% |
247,687
-114,474
| -32% | -$5.04M |
|
649
Oneok
OKE
$57.8B
| $10.6M | 0.02% |
191,571
+72,022
| +60% | +$4.67M |
|
|
K
650
DELISTED
Kellanova
K
| $10.6M | 0.02% |
158,500
+23,643
| +18% | +$1.54M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.